81% rise in Victoza sales drives Novo Nordisk earnings

Article Date: 27/04/2012 10:33
81% rise in Victoza sales drives Novo Nordisk earnings

Vacancy Search

Quick job search

Advanced Search

Latest News

FDA green light for Cubist's antibiotic

FDA green light for Cubist's antibiotic

AZ' novel PARP inhibitor Lynparza bags US approval

AZ' novel PARP inhibitor Lynparza bags US approval

New apps steers patients away from branded cold/flu meds

New apps steers patients away from branded cold/flu meds

NHS England announces new measures to encourage innovation

NHS England announces new measures to encourage innovation

Roche dumps AD trial, Kadcyla first-line disappoints

Roche dumps AD trial, Kadcyla first-line disappoints

First stem-cell therapy among seven drugs up for EU nod

First stem-cell therapy among seven drugs up for EU nod

Twenty-year study proves tamoxifen saves lives

Twenty-year study proves tamoxifen saves lives

GSK's shingle vaccine hits efficacy targets

GSK's shingle vaccine hits efficacy targets

AZ' first-in-class PARP inhibitor Lynparza wins EU nod

AZ' first-in-class PARP inhibitor Lynparza wins EU nod

Merck buys OncoEthix for $375m

Merck buys OncoEthix for $375m
more news